Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Robert McCreary Advises Kelusa Capital China in Expansion After Strong Gains

Contrary to what some people may have heard, Julian Robertson does not back Kelusa Capital China. In fact, the fund is looking for backers in order to expand after pulling in over 7% in September reports Bloomberg.


Robert McCreary Brings a Wealth of Experience to Advising Kelusa Capital China

Kelusa Capital China currently has assets valued around $55 million and is looking to increase that volume five-fold, bringing the fund to $250 million. Robert McCreary, the founder of New York-based Kelusa Capital Group, is advising. Robert McCreary is one of the infamous tiger cubs. For five years (1991-1995), he managed Asian investments at Tiger Management LLC. After leaving Tiger, McCreary founded Banyan Fund Management, which he closed in 2004. Then, he started Kelusa Capital. Kenton Leo worked for McCreary at Banyan and later Kelusa, before becoming the founding partner of Kelusa Capital China. He now manages that fund and “oversees Kelusa Capital Master Fund’s investments in Chinese stocks.”

Kenton Leo on Kelusa Capital China’s Strategy

Kenton Leo explains that Kelusa Capital China will focus on “preserving capital and [will] subsequently invest when the market panic subsides over the next 18 to 24 months.” He says, “Panic creates opportunities,” that people tend to sell assets down indiscriminately, pushing many quality stocks to all-time low valuations. In other words, he is focusing on value rather than events. Leo explains, “We’re very focused on thinking about picking companies that will underperform and outperform the market, and constructing a portfolio where company fundamentals drive the fund performance, rather than big macro events.”

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!